Jpmorgan Chase & CO Lantheus Holdings, Inc. Put Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LNTH
# of Institutions
509Shares Held
67.3MCall Options Held
1.19MPut Options Held
837K-
Black Rock Inc. New York, NY8.6MShares$940 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.57MShares$827 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.33MShares$364 Million0.15% of portfolio
-
State Street Corp Boston, MA2.49MShares$272 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.28MShares$249 Million0.89% of portfolio
About Lantheus Holdings, Inc.
- Ticker LNTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 68,741,904
- Market Cap $7.52B
- Description
- Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...